-
Persistence of Operant Responding for Food After Prior Cocaine Exposure in Fischer 344 But Not Lewis Rats The American Journal on Addictions (IF 2.371) Pub Date : 2021-04-02 Shadab Forouzan, Steven J. Nieto, Therese A. Kosten
Chronic cocaine exposure has differential neural effects in Fischer 344 (F344) vs Lewis inbred rats that may explain strain‐dependent differences during acquisition vs maintenance of cocaine self‐administration. We assessed whether prior cocaine exposure alters operant responding for food across various phases (acquisition, maintenance, extinction, spontaneous recovery, reinitiation) in these strains
-
Substance Use, Gambling, Binge‐Eating, and Hypersexuality Symptoms Among Patients Receiving Opioid Agonist Therapies The American Journal on Addictions (IF 2.371) Pub Date : 2021-03-30 Meagan M. Carr, Jennifer D. Ellis, Karen K. Saules, Jamie L. Page, Angela Staples, David M. Ledgerwood
Patients receiving opioid agonist therapies have high rates of psychiatric comorbidity. Some data suggest that comorbidity is associated with poorer treatment outcomes. The current study assessed predictors of multiple putative addictive behaviors among patients receiving opioid agonist therapies.
-
β‐Arrestin 2 (ARRB2) Polymorphism is Associated With Adverse Consequences of Chronic Heroin Use The American Journal on Addictions (IF 2.371) Pub Date : 2021-03-30 Klevis K. Karavidha, Margit Burmeister, Mark K. Greenwald
β‐arrestin 2 is an intracellular protein recruited during the activation of G‐protein‐coupled receptors. In preclinical studies, β‐arrestin 2 has been implicated in µ‐opioid receptor desensitization and internalization and the development of opioid tolerance and dependence. The present study investigated relationships between variants in the gene encoding β‐arrestin 2 (ARRB2) and clinically relevant
-
Comparing the Rate of Nicotine Metabolism Among Smokers With Current or Past Major Depressive Disorder The American Journal on Addictions (IF 2.371) Pub Date : 2021-03-26 Robert Schnoll, E. Paul Wileyto, Anna‐Marika Bauer, Erica Fox, Frank Leone, Caryn Lerman, Rachel F. Tyndale, Tony P. George, Larry Hawk, Paul Cinciripini, Mackenzie Quinn, Janelle Purnell, Jane Hatzell, Brian Hitsman
Persons with current or past major depressive disorder (MDD) vs those without have higher smoking rates. The nicotine metabolite ratio (NMR) represents variation in the rate of nicotine metabolism and has been associated with smoking behaviors and response to tobacco treatments. We compared NMR between smokers with current or past MDD (MDD+) vs smokers without MDD (MDD−). We also assessed correlates
-
Prescription Drug Monitoring Program: Access in the First Year The American Journal on Addictions (IF 2.371) Pub Date : 2021-03-24 Mitchell Crawford, Pantea Farahmand, Erin Kate McShane, Abigail Z. Schein, Janet Richmond, Grace Chang
Prescription Drug Monitoring Programs (PDMP) detect high‐risk prescribing and patient behaviors. This study describes the characteristics associated with documented PDMP access when prescribing opioids.
-
Demographic, Behavioral, and Proximal Risk Factors for Gambling Disorder in the US Military The American Journal on Addictions (IF 2.371) Pub Date : 2021-03-24 Abigail L. Garvey Wilson, Kevin G. O'Gallagher, Xian Liu, Jennifer G. Greenberg, Jean L. Otto, Marjorie S. Campbell, Bradley E. Belsher, Daniel P. Evatt
To estimate the diagnostic prevalence and incidence of gambling disorder among United States service members and to identify associated risk factors, including demographics, history of mental illness or substance misuse, and proximity to legalized gambling vicinities.
-
Brief Report: The Impact of COVID‐19 on Emergency Department Overdose Diagnoses and County Overdose Deaths The American Journal on Addictions (IF 2.371) Pub Date : 2021-03-19 Jacob Shreffler, Hugh Shoff, J. Jeremy Thomas, Martin Huecker
We sought to understand the impact of COVID‐19 on emergency department (ED) overdoses and county coroner verified overdose deaths.
-
Chronic Pain Among Patients With an Opioid Use Disorder The American Journal on Addictions (IF 2.371) Pub Date : 2021-03-19 Zill‐E Huma Latif, Ingeborg Skjærvø, Kristin K. Solli, Lars Tanum
Chronic pain is not well understood in opioid‐dependent populations. We report the prevalence of chronic pain and pain characteristics in an opioid‐dependent population by treatment type and gender.
-
Examining Associations Between Licensed and Unlicensed Outlet Density and Cannabis Outcomes From Preopening to Postopening of Recreational Cannabis Outlets The American Journal on Addictions (IF 2.371) Pub Date : 2020-12-30 Eric R. Pedersen, Caislin L. Firth, Anthony Rodriguez, Regina A. Shih, Rachana Seelam, Lisa Kraus, Michael S. Dunbar, Joan S. Tucker, Beau Kilmer, Elizabeth J. D'Amico
To expand on epidemiologic studies examining associations between the legalization of recreational cannabis and use among young adults, we examined the associations between licensed and unlicensed cannabis outlet density and cannabis outcomes.
-
The Efficacy of Combined Electroacupuncture and Auricular Pressure on Sleep Quality in Patients Receiving Methadone Maintenance Treatment The American Journal on Addictions (IF 2.371) Pub Date : 2020-12-30 Kai‐Chiang Yu, Han‐Ting Wei, Shang‐Chih Chang, Kuei‐Yu Huang, Chung‐Hua Hsu
Previous studies have revealed that the electroacupuncture or auricular‐point pressure as a single treatment approach is beneficial for relieving insomniac symptoms among patients under methadone maintenance treatment (MMT). This study is designed to evaluate the clinical efficacy of combining two treatments.
-
Hazardous Alcohol Use, Impulsivity, and HIV‐Risk Behavior Among HIV‐Positive Russian Patients With a History of Injection Drug Use The American Journal on Addictions (IF 2.371) Pub Date : 2020-12-30 Kathryn Chavez, Tibor P. Palfai, Debbie M. Cheng, Elena Blokhina, Natalia Gnatienko, Emily K. Quinn, Evgeny Krupitsky, Jeffrey H. Samet
Previous findings on the association between hazardous drinking and HIV‐risk behavior have been equivocal, varying by population and individual difference factors. This study examined associations between hazardous drinking, impulsivity, and HIV‐risk behaviors among HIV‐positive Russian patients with a history of injection drug use (IDU), not on antiretroviral therapy.
-
A Healthcare System‐Level Intervention to Increase Naloxone Availability for Patients With Opioid Prescriptions The American Journal on Addictions (IF 2.371) Pub Date : 2020-12-30 Jonathan E. Siff, David Margolius, Joan Papp, Bernard Boulanger, Brook Watts
National guidelines recommend prescribing naloxone to patients receiving chronic opioids. However, provider adherence to naloxone co‐prescribing best practices is poor and knowledge gaps for improvement efforts are large. As part of a system‐wide quality improvement intervention to improve opioid safety, we sought to improve access to naloxone for patients with opioid prescriptions.
-
Microinduction of Buprenorphine/Naloxone: A Review of the Literature The American Journal on Addictions (IF 2.371) Pub Date : 2020-12-30 Saeed Ahmed, Siddhi Bhivandkar, Brady B. Lonergan, Joji Suzuki
Buprenorphine's high‐binding affinity as a partial µ‐opioid agonist displaces preexisting full agonists causing precipitated withdrawal, which requires most individuals starting buprenorphine to endure moderate withdrawal prior to induction to avoid precipitated withdrawal. A novel approach called microinduction has emerged to remove this prerequisite. Our aim is to review the literature on these alternative
-
Cingulate Cortex Structural Alterations in Substance Use Disorder Psychiatric Inpatients The American Journal on Addictions (IF 2.371) Pub Date : 2020-11-24 Hyuntaek Oh, Savannah Gosnell, Tien Nguyen, Tiffany Tran, Thomas R. Kosten, Ramiro Salas
Substance use disorder (SUD) includes maladaptive patterns of substance use despite negative consequences. Previous structural neuroimaging studies showed some structural alterations in SUD, but it remains unknown whether these alterations are specifically associated with SUD or common comorbidities. This study attempts to validate the findings of structural differences between SUD, healthy controls
-
Increasing Heroin‐Methamphetamine (Goofball) Use and Related Morbidity Among Seattle Area People Who Inject Drugs The American Journal on Addictions (IF 2.371) Pub Date : 2020-12-10 Sara N. Glick, Kathryn S. Klein, Joe Tinsley, Matthew R. Golden
Methamphetamine use is increasing in the United States, potentially including the simultaneous injection of methamphetamine with heroin (goofball). We compared demographic, behavioral, contextual, and health factors among people who inject drugs (PWID) in the Seattle area and who reported that their main drug was goofball, heroin, or methamphetamine.
-
Treatment Goals and Alcohol Use Outcomes in Veterans With Comorbid Alcohol Dependence and Posttraumatic Stress Disorder The American Journal on Addictions (IF 2.371) Pub Date : 2020-12-08 Brian E. Lozano, Nicholas P. Allan, Daniel F. Gros, Jennifer Jones, Sudie E. Back
Previous research demonstrates the utility of goals in attaining improved drinking outcomes. Considerably less is known about the association between substance use goals and outcomes among persons with comorbid substance use disorder (SUD) and posttraumatic stress disorder (PTSD). This secondary analysis examined the association between alcohol use outcomes and participants’ treatment entry substance
-
Systematic Review and Meta‐Analysis: Treatment of Substance Use Disorder in Attention Deficit Hyperactivity Disorder The American Journal on Addictions (IF 2.371) Pub Date : 2020-12-08 Dimy Fluyau, Neelambika Revadigar, Christopher G. Pierre
Treating substance use disorder (SUD) in patients with co‐occurring attention deficit hyperactivity disorder (ADHD) and SUD may lower medical, psychiatric, and social complications. We conducted a systematic review with meta‐analysis to investigate the clinical benefits of pharmacological interventions to treat SUD in patients with ADHD.
-
A Comparison of Mental and Behavioral Health Risks Factors Associated With Current Dual Use of Electronic Cigarette and Conventional Tobacco Cigarettes With Exclusive Tobacco Cigarette Use and Nonuse Among Adults in the United States The American Journal on Addictions (IF 2.371) Pub Date : 2020-12-03 Nene Okunna
While health risks associated with tobacco cigarette use are well‐known, additional risks of dual use are poorly understood. This study compared mental and behavioral health risk factors associated with the current dual use of e‐cigarettes and conventional tobacco cigarettes with current exclusive users of tobacco cigarettes and nonusers of either e‐cigarettes or tobacco cigarettes.
-
Main and Interactive Effects of Nicotine Product Type on Sleep Health Among Dual Combustible and E‐Cigarette Users The American Journal on Addictions (IF 2.371) Pub Date : 2020-11-24 Christine J. So, Jessica M. Meers, Candice A. Alfano, Lorra Garey, Michael J. Zvolensky
E‐cigarette use is associated with concurrent use of combustible cigarettes among adults and may increase the risk of future combustible cigarette use in adolescents and young adults. Detrimental effects of combustible cigarette use on sleep health are well documented, but little is known about the additive effects of concurrent e‐cigarette use. The current study examined the main and interactive effects
-
Brief Report: Predictors of Relapse for Patients With Dextromethorphan Dependence The American Journal on Addictions (IF 2.371) Pub Date : 2020-11-23 Jie Xu, Hang Ou, Pei Sun, Shiyang Qin, Ti‐Fei Yuan
The recreational use of dextromethorphan (DXM) triggers dependence. The pattern and clinical predictors of relapse are unclear.
-
Pay for Performance and Treatment Outcome in Agonist Treatment for Opioid Use Disorder The American Journal on Addictions (IF 2.371) Pub Date : 2020-10-01 Emily Loscalzo, Alexander Levit, Robert C. Sterling, Stephen P. Weinstein
Pay for performance (P4P) models have become more popular in reimbursement for medical services, including treatment for substance use disorders. However, studies have not examined whether P4P has an impact on treatment outcome in the individual in opioid agonist treatment (OAT). Thus, the present study was conducted at the individual level, rather than the programmatic level, to determine whether
-
Addiction Psychiatry and Addiction Medicine: The Evolution of Addiction Physician Specialists. The American Journal on Addictions (IF 2.371) Pub Date : 2020-09-09 Edward V Nunes,Kevin Kunz,Marc Galanter,Patrick G O'Connor
Addiction Psychiatry and Addiction Medicine are two physician subspecialities recognized by the American Board of Medical Specialties (ABMS) that focus on providing care for patients with substance use disorders. Their shared and distinct historical roots are reviewed, and their respective ABMS board examination content areas and Accreditation Council on Graduate Medical Education (ACGME) fellowship
-
Establishing the First Annual Meetings of the American Academy of Addiction Psychiatry. The American Journal on Addictions (IF 2.371) Pub Date : 2020-09-09 Roger D Weiss
This paper describes the initial meetings of the American Academy of Addiction Psychiatry, and it compares and contrasts these relatively small meetings with the much larger meetings today. The paper is centered on the organization's initial focus on establishing itself in the mainstream of medicine and psychiatry. (Am J Addict 2020;00:00–00)
-
Building Outreach and Diversity in the Field of Addictions. The American Journal on Addictions (IF 2.371) Pub Date : 2020-09-01 Ayana Jordan,Oluwole Jegede
-
Women in Addiction Psychiatry: How Can Specialty Societies Play a Role in Closing the Gender Gap in Academic Medicine? The American Journal on Addictions (IF 2.371) Pub Date : 2020-09-01 Shelly F Greenfield,Kathleen T Brady
-
The American Psychiatric Association Creates a Subspecialty: The Birth of Addiction Psychiatry, Early Years of the American Academy of Addiction Psychiatry. The American Journal on Addictions (IF 2.371) Pub Date : 2020-09-01 Richard Frances,Edger Nace,Edward Khantzian,Edward Kaufman
-
The Development of Fellowship Training in Addiction Psychiatry. The American Journal on Addictions (IF 2.371) Pub Date : 2020-09-01 Marc Galanter
-
Clinical Update: What is Old is New Again: Rediscovering Narrative in Healthcare and Charting a Future for Addiction Specialists. The American Journal on Addictions (IF 2.371) Pub Date : 2020-09-01 Jeffrey J DeVido,Martin F Epson
-
AAAP: The Early Years. The Contribution of Jeanne Trumble-Hejduk, AAAP Executive Director, 1995-2002. The American Journal on Addictions (IF 2.371) Pub Date : 2020-09-01 Michael H Gendel
-
Addiction, Race, and the Structurally Vulnerable. The American Journal on Addictions (IF 2.371) Pub Date : 2020-09-01 Oluwole Jegede
-
AAAP Becomes a National Presence: The KCW Years. The American Journal on Addictions (IF 2.371) Pub Date : 2020-09-01 Frances R Levin
-
Commentary: Proposed Model State Cannabis Laws to Reduce Harms. The American Journal on Addictions (IF 2.371) Pub Date : 2020-09-01 Arthur Robin Williams,Kevin P Hill,Richard N Rosenthal,Hilary S Connery,Justine W Welsh
-
A Celebration of the 35th Anniversary of the American Academy of Addiction Psychiatry. The American Journal on Addictions (IF 2.371) Pub Date : 2020-09-01 John A Renner
-
The Promise of Tele-MAT. The American Journal on Addictions (IF 2.371) Pub Date : 2020-09-01 Corneliu N Stanciu
-
Evolution of the Journal of the American Academy of Addiction Psychiatry: The American Journal on Addictions. The American Journal on Addictions (IF 2.371) Pub Date : 2020-09-01 Thomas R Kosten,Richard Frances,Coreen B Domingo
-
Advocacy and Public Policy Efforts of the American Academy of Addiction Psychiatry. The American Journal on Addictions (IF 2.371) Pub Date : 2020-09-01 Richard N Rosenthal,Justine W Welsh,Hilary S Connery,Brian S Barnett,Jeffrey DeVido,Kevin Hill,Frances R Levin,Arthur R Williams,Shelly F Greenfield
-
Multiple Psychiatric Morbidity and Continued Use of Naltrexone for Alcohol Use Disorder. The American Journal on Addictions (IF 2.371) Pub Date : 2020-08-17 Srinivas B Muvvala,Stephanie S O'Malley,Robert Rosenheck
Despite substantial evidence of the efficacy of naltrexone in treating alcohol use disorder (AUD), naltrexone is used infrequently and often for short durations. Understanding factors related to the initiation and continued use of naltrexone could identify targets for improving its use in clinical practice.
-
Brief Report: Rates of Fentanyl Use among Psychiatric Emergency Room Patients. The American Journal on Addictions (IF 2.371) Pub Date : 2020-08-10 Mohamed Elmarasi,Gabriela Garcia-Vassallo,Sheldon Campbell,Brian Fuehrlein
Opioid overdose‐related deaths increased from approximately 18 000 deaths in 2007 to 46 802 deaths in 2018. Fentanyl is primarily responsible for the increase in opioid overdose deaths from 2011 through 2017. The primary aim of this study is to determine the rates of fentanyl in the urine drug screens of all patients who presented to the psychiatric emergency room at VA Connecticut, over 7 months in
-
The Increasing Prevalence of Fentanyl: A Urinalysis-Based Study Among Individuals With Opioid Use Disorder in New York City. The American Journal on Addictions (IF 2.371) Pub Date : 2020-08-10 Suky Martinez,Jermaine D Jones,Laura Brandt,Aimee N C Campbell,Rebecca Abbott,Sandra D Comer
Opioid‐related overdose deaths in North America have increased drastically, partially due to the increased prevalence of illicitly manufactured fentanyl. The current study sought to assess the prevalence and intentionality of fentanyl use among individuals with opioid use disorder (OUD).
-
Shifts in Unintentional Exposure to Drugs Among People Who Use Ecstasy in the Electronic Dance Music Scene, 2016-2019. The American Journal on Addictions (IF 2.371) Pub Date : 2020-07-28 Joseph J Palamar,Alberto Salomone
Electronic dance music (EDM) party attendees who use ecstasy (3,4‐methylenedioxymethamphetamine [MDMA], Molly) are at high risk for ingesting adulterant drugs, but little is known regarding trends in exposure. We sought to determine whether adulteration has shifted in recent years.
-
Buprenorphine Medication for Opioid Use Disorder: A Study of Factors Associated With Postpartum Treatment Retention. The American Journal on Addictions (IF 2.371) Pub Date : 2020-07-16 Shona Ray-Griffith,Emily Tharp,Jessica L Coker,David Catlin,Bettina Knight,Zachary N Stowe
The factors associated with medication for opioid use disorder (MOUD) treatment retention among pregnant women with opioid use disorder (OUD) are largely unknown. This study sought to characterize factors associated with postpartum treatment retention.
-
Alcohol Craving and Psychiatric Disorders Among Current Drinkers. The American Journal on Addictions (IF 2.371) Pub Date : 2020-07-15 Gihyun Yoon,Katie Thompson,Jahn K Hakes,Joseph Westermeyer,Ismene L Petrakis,Suck Won Kim
Previous research has shown that alcohol craving is associated with psychiatric comorbidities. However, no population studies have examined the odds of psychiatric disorders in cravers and noncravers. The purpose of this study was to investigate current prevalence rates and odds ratios of psychiatric disorders among alcohol drinkers with and without alcohol craving in a population‐based sample. We
-
Case Report: Buprenorphine-A Treatment for Psychological Pain and Suicidal Ideation? The American Journal on Addictions (IF 2.371) Pub Date : 2020-07-14 Ori-Michael Benhamou,Sean Lynch,Lidia Klepacz
Buprenorphine is commonly used to manage opioid use disorder; however, the literature describes its potential role in treating treatment‐resistant depression.
-
Method for Successfully Inducting Individuals Who Use Illicit Fentanyl Onto Buprenorphine/Naloxone. The American Journal on Addictions (IF 2.371) Pub Date : 2020-06-23 Denis Antoine,Andrew S Huhn,Eric C Strain,Gavin Turner,Jasmyne Jardot,Alexis S Hammond,Kelly E Dunn
Individuals exposed to fentanyl are at risk of precipitated withdrawal using typical buprenorphine/naloxone induction procedures.
-
Race, Ethnicity, and Clinical Features of Alcohol Use Disorder Among US Military Veterans: Results From the National Health and Resilience in Veterans Study. The American Journal on Addictions (IF 2.371) Pub Date : 2020-06-22 Meagan M Carr,Marc N Potenza,Kristin L Serowik,Robert H Pietrzak
Alcohol use disorder (AUD) is highly prevalent in US military veterans, though little is known about whether the psychiatric comorbidities and functional outcomes (ie, clinical features) of AUD differ across race/ethnic groups. We aimed to identify differences in the clinical features of veterans with AUD by race/ethnicity.
-
Examining Overdose and Homelessness as Predictors of Willingness to Use Supervised Injection Facilities by Services Provided Among Persons Who Inject Drugs. The American Journal on Addictions (IF 2.371) Pub Date : 2020-06-10 Shannon R Kenney,Bradley J Anderson,Genie L Bailey,Debra S Herman,Micah T Conti,Michael D Stein
Internationally, supervised injection facilities (SIFs) have demonstrated efficacy in reducing rates of overdose and promoting entry into treatment among persons who inject drugs (PWID); however, they remain unavailable in the United States. Early findings examining American PWID illustrate high overall willingness to use SIFs. The current study expands upon this research by examining PWID's likelihood
-
Evaluation of a Novel Protocol for Assessment and Treatment of Alcohol Withdrawal Syndrome in Psychiatric Inpatients. The American Journal on Addictions (IF 2.371) Pub Date : 2020-06-03 Michael Butterfield,Lucas Thorne-Humphrey,Joji Suzuki,Nicole Herschenhous
Despite the high incidence of alcohol withdrawal syndrome (AWS) in psychiatric inpatients, standardized methods for assessing and treating AWS have been studied only once before in this population. We evaluated a novel AWS assessment and treatment protocol designed for psychiatric inpatients.
-
Brief Report: Relationship Between Cotinine Levels and Peripheral Endogenous Concentrations of Oxytocin, β-Endorphin, and Orexin in Individuals With Both Alcohol and Nicotine Use Disorders. The American Journal on Addictions (IF 2.371) Pub Date : 2020-06-02 Carolina L Haass-Koffler,Roberta Perciballi,Zoe E Brown,Mary R Lee,William H Zywiak,Jonathan Kurtis,Robert M Swift,Lorenzo Leggio
In this secondary analysis of a pilot clinical trial with individuals with alcohol and nicotine use disorders, we investigate the relationship between serum concentrations of oxytocin, β‐endorphin, melatonin, α‐melanocyte‐stimulating hormone, substance P, and orexin, with objective biomarkers (salivary cotinine and serum γ‐glutamyl transferase [GGT]) as well as with self‐reported smoking and alcohol
-
Zonisamide as an Adjunctive Treatment to Cognitive Processing Therapy for Veterans With Posttraumatic Stress Disorder and Comorbid Alcohol Use Disorder: A Pilot Study. The American Journal on Addictions (IF 2.371) Pub Date : 2020-05-27 Ismene Petrakis,Elizabeth Ralevski,Albert J Arias,Diana DeNegre,Jenelle Newcomb,Mayumi Gianoli,Elissa McCarthy,Sarah Meshberg-Cohen,Gihyun Yoon
There are high rates of comorbid alcohol use disorder (AUD) among those who have posttraumatic stress disorder (PTSD). Ideally, treatment for comorbidity should address both disorders simultaneously. Zonisamide, an anticonvulsant, may be effective in decreasing alcohol use and may attenuate symptoms of PTSD. Treatment strategies can include medication in combination with a proven evidence‐based psychotherapy
-
Substance Use and Mental Health in Emerging Adult Vs Older Adult Men and Women With Opioid Use Disorder. The American Journal on Addictions (IF 2.371) Pub Date : 2020-05-21 Celestina Barbosa-Leiker,Aimee N C Campbell,Martina Pavlicova,Jennifer Scodes,A Kathleen Burlew,Mary Hatch-Maillette,Sarah E Mennenga,Shannon G Mitchell,Patricia Novo,Edward V Nunes,John Rotrosen,Shelly F Greenfield
We examined age differences across genders in clinical characteristics in emerging adult (≤25 years) vs older adult patients (26+ years) with opioid use disorder (OUD).
-
Alexithymia, Emotion-Regulation Strategies, and Traumatic Experiences in Prenatally Cocaine-Exposed Young Adults. The American Journal on Addictions (IF 2.371) Pub Date : 2020-05-20 Kristen P Morie,Zu Wei Zhai,Marc N Potenza,Linda C Mayes
Exposure to early‐life trauma may lead to maladaptive characteristics such as alexithymia, and thus to poorer emotional regulation. This relationship may also be influenced by exposure to substances prenatally. We hypothesized that increased alexithymia would be seen in those with prenatal cocaine exposure (PCE). Additionally, we hypothesized that early‐life trauma would be associated with alexithymia
-
Disentangling the Social Context of Nonmedical Use of Prescription Stimulants in College Students. The American Journal on Addictions (IF 2.371) Pub Date : 2020-05-20 Timothy E Wilens,MaryKate Martelon,Amy Yule,Tamar A Kaminski,Colin Burke,Ty S Schepis,Sean E McCabe
The aim of this study was to investigate the social context of nonmedical use of prescription stimulants (NMUPS) among college students who endorsed NMUPS with co‐occurring substance use disorders (SUD) compared with those without co‐occurring SUDs.
-
Methadone-Assisted Opiate Withdrawal and Subsequent Heroin Abstinence: The Importance of Psychological Preparedness. The American Journal on Addictions (IF 2.371) Pub Date : 2020-05-19 Steve Jones,Barbara Jack,Julie Kirby,Thomas L Wilson,Philip N Murphy
Treatment guidelines emphasize patients’ readiness for transitioning from opiate substitution treatment (OST) to opiate withdrawal and abstinence. Psychological preparedness indicators for this transition were examined.
-
Systematic Review: Treatment for Addictive Disorder in Transplant Patients. The American Journal on Addictions (IF 2.371) Pub Date : 2020-05-14 Walter Luchsinger,Paula Zimbrean
The number of patients with substance use disorders in need for organ transplantation is expected to increase. Patients with addictive disorders are considered a higher risk of negative outcomes after organ transplantation due to the impact of substance use upon medical status and adherence with treatment. The goal of this systematic review was to assess the current literature on treatment for addiction
-
Ten Years of Experience With Buprenorphine in a Private Psychiatric Outpatient Practice. The American Journal on Addictions (IF 2.371) Pub Date : 2020-05-14 Robert Feder
There have been few reports of buprenorphine treatment of opioid use disorder in private psychiatric practice. This report describes such a patient population and the outcomes obtained.
-
Mobile, Community-Based Buprenorphine Treatment for Veterans Experiencing Homelessness With Opioid Use Disorder: A Pilot, Feasibility Study. The American Journal on Addictions (IF 2.371) Pub Date : 2020-05-04 Theddeus Iheanacho,Kevin Payne,Jack Tsai
Adults experiencing homelessness with opioid use disorder (OUD) utilize buprenorphine (BUP), a first‐line medication for OUD, at very low rates. Innovative and tailored approaches are needed to reduce barriers to treatment and increase utilization of BUP in this population. This study describes a pilot Mobile Community‐based Access Team (M‐CAT) that used mobile technology and FaceTime in addition to
-
Associations Between Self-Reported and Biological Measures of Nicotine Consumption Among Young Adult Nondaily Cigarette Smokers. The American Journal on Addictions (IF 2.371) Pub Date : 2020-05-02 Neal Doran,John B Correa,Mark G Myers,Lyric Tully
Intermittent, dual use of cigarettes and e‐cigarettes is a common pattern among youth and young adults. However, little is known about the validity of self‐report measures of nicotine consumption in these populations. The goal of the present study was to examine associations between self‐reported frequency of cigarette and e‐cigarette use and nicotine levels in hair samples at two assessments 1 year
-
Editorial: The Year in Review Amidst the COVID-19 Crisis. The American Journal on Addictions (IF 2.371) Pub Date : 2020-05-01 Thomas R Kosten,Coreen B Domingo
-
-
Symposia, Case Conference, and Medical Update. The American Journal on Addictions (IF 2.371) Pub Date : 2020-05-01
Contents have been reproduced by permission of the publishers.